logo
Select company
Select metric
Ticker Information

Ticker

DAWN

Company Name

DAY ONE BIOPHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

DAY ONE BIOPHARMACEUTICALS INC - Price to Free Cash Flow Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

DAWN - P/FCF Historical data
DateFree Cash FlowMarket CapitalizationPrice to Free Cash Flow
6/30/2025$ -65.49M$ 704.73M0
3/31/2025$ 18.13M$ 708.52M39.07
12/31/2024$ 27.72M$ 1.2B43.22
9/30/2024$ 17.77M$ 1.46B82.14
6/30/2024$ -69.37M$ 1.22B0
3/31/2024$ -170.79M$ 1.45B0
12/31/2023$ -147.08M$ 1.37B0
9/30/2023$ -141.01M$ 1.06B0
6/30/2023$ -127.12M$ 1.08B0
3/31/2023$ -114.33M$ 1.06B0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • DAY ONE BIOPHARMACEUTICALS INC's latest trailing twelve months (TTM) P/FCF stands at 0.
  • Over the past 5 years, DAY ONE BIOPHARMACEUTICALS INC's average P/FCF has been 54.81.
  • The median P/FCF for DAY ONE BIOPHARMACEUTICALS INC during this period was 43.22
  • DAY ONE BIOPHARMACEUTICALS INC reached its highest P/FCF over the past 5 years at 82.14.
  • The lowest P/FCF recorded by DAY ONE BIOPHARMACEUTICALS INC in the same timeframe 39.07

DAY ONE BIOPHARMACEUTICALS INC's P/FCF vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

P/FCF Benchmarks
CompanyP/FCF
STOK : STOKE THERAPEUTICS INC 12.13AKBA : AKEBIA THERAPEUTICS INC -DNA : GINKGO BIOWORKS HOLDINGS INC -GERN : GERON CORP -MRVI : MARAVAI LIFESCIENCES HOLDINGS INC -KROS : KEROS THERAPEUTICS INC 11.03NAGE : NIAGEN BIOSCIENCE INC 35.78PHAT : PHATHOM PHARMACEUTICALS INC -ANAB : ANAPTYSBIO INC -XNCR : XENCOR INC -

Definition of Price to Free Cash Flow

[Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
Market Cap / FCF
(=) P/FCF
P/FCF for DAY ONE BIOPHARMACEUTICALS INC is calculated as follows: Market Cap [ $ 0 ] / FCF [ $ -13.58M ]
(=) P/FCF [ 0 ]

DAWN - Price to Free Cash Flow, Last 5 years

39.07

Minimum

Mar 31, 2025

82.14

Maximum

Sep 30, 2024

54.81

Average

43.22

Median

P/FCF Benchmark Analysis

The chart above depicts the distribution of P/FCF for companies in the Total Stock Market. The average P/FCF of the companies is 18.32 with a standard deviation of 12.94.
The following table provides additional summary stats:
P/FCF in the Market:
filtered constituents2.23K
min0.06
max60.45
average18.32
median14.76
std12.94